This content is machine translated Heterogeneous safety profiles for dermatological and endocrine AEs Not all GLP1-RA are the same GLP1-RA effectively improve blood glucose, weight and cardiovascular parameters, but are increasingly in focus due to possible additional side effects such as alopecia and neuropsychiatric effects. A large real-world analysis...…
View Post 4 min This content is machine translated GLP1 receptor agonists Positive influence on substance use and addiction GLP1 receptor agonists are gaining increasing recognition, not only for their metabolic benefits in type 2 diabetes, but also for potential effects beyond glycemic control. New experimental evidence suggests that...…
View Post 3 min This content is machine translated Development of a quintuple agonist New strategy in the fight against obesity and T2D The treatment of obesity and type 2 diabetes is increasingly shifting to newer incretin drugs, including GLP1 receptor agonists (single agonists such as semaglutide) and GIP- and GLP1-RA (dual agonists...…
